|Day Low/High||30.00 / 30.20|
|52 Wk Low/High||27.60 / 35.41|
The FDA approved 11 different hematological treatments this year after approving 11 in the previous two years combined.
Bayer, which has agreed to buy U.S. seeds maker Monsanto, dipped more than 3% after cutting its outlook for drugs sales and warning of difficult times in U.S. consumer health.
European markets pulled down by quarterly earnings at bank.
The German plastics maker gained 6% after posting a 50% Ebitda increase and announcing a share buyback, handing Bayer more firepower to fund its Monsanto takeover.
Sale should help Bayer's $66 billion takeover of Monsanto
Investors await Tesla's earnings report on Wednesday.
Tesla must find some external green.
The European Commission said Bayer wants to avoid a lengthy review.
Poor earnings and an FDA gut-punch to the tobacco industry sank markets
A string of earnings disappointments and poor economic data hit markets.
Bayer says Monsanto acquisition 'on track'.
Global equity rally takes a breather.
Bank and commodity stocks dragged European benchmarks lower Tuesday as mining stocks pared Monday's gains and the second-quarter earnings season got underway.
The Berkeley site, which includes Bayer's global biotechnology development and product supply organizations, is the company's single plant that manufactures and distributes its Hemophilia A treatments
The first confirmed case of the plague this year was diagnosed in June when a 63-year-old man contracted the disease.
The biggest U.S. grocer wants winter melons to taste just as sweet as the summer ones.
European benchmarks rose Tuesday as fallers from the previous session paired losses and concerns over political risks receded, in favor of a renewed focus on economic data and monetary policy.
The sale stands to potentially be valued at $2.5 billion to $3 billion.
European benchmarks were roundly higher at the close Friday following what was a volatile session for London, with British politics delivering yet another upset to pundits and pollsters alike.
Bayer is offering 1 billion euros of bonds exchangeable into Covestro shares maturing in 2020.
European stocks fell Tuesday as investors shunned commodities and other risk stocks on a cocktail of concerns, ranging from the Middle East to domestic terrorism and politics.
While causing upset among politicians and some business leaders, President Donald Trump's withdrawal of the U.S. from the Paris Agreement helped boost stock prices across the chemicals and automotive sectors.
The divestment was part of a divestment required by South Africa's competition committee.
European stocks fell for the first session in nearly a week Thursday as investors reacted to a mixed set of regional corporate earnings.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.